University of Birmingham (U.K.) signs licensing deal with Innova Medical Group – the world's largest COVID-19 at-home self-test provider - to Commercialize New Proven Testing Method in the Global ...
The proportion of people with current covid-19 infection missed by the Innova lateral flow test (LFT) is substantial enough to be of clinical importance, particularly when testing people without ...
SYGNIS AG, under the Innova Biosciences (Innova) brand name, a specialist provider of bioconjugation products and services, today announced it has established a partnership with Abingdon Health Ltd ...
Bond Digital Health Ltd. landed £1 million (US$1.3 million) from investors to expand development of its Transform data management system for lateral flow diagnostic tests. The technology connects to ...
Lateral flow tests (LFTs) are widely used across healthcare, food safety and environmental monitoring, providing rapid, on-site results. But challenges with sensitivity, flexibility and usability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback